Clear, written guidelines on anaphylaxis management, including referral pathways, should be in place in all healthcare, work and school settings |
96 |
Plans should be reviewed if a severe allergic reaction occurs |
96 |
Oral antihistamines, inhalers and/or injectable adrenaline (e.g. Epipen), if prescribed, should be accompanied by information on their use |
91 |
Anaphylaxis management plans should be reviewed annually including reassessment of patient/parent knowledge of anaphylaxis management and emergency treatment |
87 |
Quality Outcome Framework (QOF) targets for anaphylaxis reviews in primary care would improve standards of care |
86 |
Plans should be reviewed when a child starts nursery or a new school |
83 |
Anaphylaxis management plans should be personalized to the patient's circumstances and tailored to age |
82 |
Anaphylaxis management plans should focus on emergency care. Long-term management plans should be addressed in a separate document |
80 |